FDA Warns of Security Holes in Medtronic’s Insulin Pumps
Certain models of Medtronic’s MiniMed insulin pumps have potential cybersecurity risks and should be swapped out for newer models, the FDA advised.
The company recalled multiple pumps, including the MiniMed 508 and ten MiniMed Paradigm models and is now offering alternative pumps that don’t have the security vulnerabilities.
Hackers may be able to connect wirelessly to the devices and change the settings, giving them control over insulin delivery to the patient. This could cause hypoglycemia or halt the delivery of insulin.